4//SEC Filing
Ultragenyx Pharmaceutical Inc. 4
Accession 0001209191-14-047792
$RARECIK 0001515673operating
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:15 PM ET
Size
5.2 KB
Accession
0001209191-14-047792
Insider Transaction Report
Form 4
Nadav Eran
Director
Transactions
- Award
Stock Option (Right to Buy)
2014-07-10+7,500→ 7,500 totalExercise: $40.37Exp: 2024-07-09→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earlier of (i) the issuer's next Annual Meeting of Stockholders and (ii) July 10, 2015.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001515673
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:15 PM ET
- Size
- 5.2 KB